Radiation from mammograms and x-rays may increase the risk for developing breast cancer in young women who are already at highest risk for the disease.
Radiation from mammograms and x-rays may increase the risk for developing breast cancer in young women who are already at highest risk for the disease-those with BRCA1 or BRCA2 mutations-and those with a familial predisposition, according to the findings of a recent study from the Netherlands.
The study included pooled data on about 12,000 high-risk women from the United States and Europe who had participated in 6 previous peer-reviewed studies (median age, 45 years).
Researchers found that the risk for breast cancer was 1.5 times greater among the high-risk women who had been exposed to low-dose radiation (ie, mammograms or chest x-rays) than among the unexposed high-risk women. In addition, high-risk women exposed to low-dose radiation before the age of 20 and those with 5 or more exposures were 2.5 times more likely to develop the disease than were other high-risk women who had not been exposed to radiation.
These findings do not pertain to women with average risk for developing breast cancer.
Greuter MJ, Jansen-van der Weide MC, Jacobi CE, et al. The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer risk. Eur J Cancer. 2009. Epub ahead of print. doi:10.1016/j.ejca.2009.10.030.
Variations found in testosterone therapy for women with HSDD
May 7th 2024Dive into the intricate landscape of testosterone therapy prescriptions among women with hypoactive sexual desire disorder, revealing diverse patterns in duration, administration routes, and estrogen co-administration.
Read More
Impact of weight, ferritin, and nutrition education on postpartum depression risk
May 7th 2024A recent study highlights the role of weight gain, ferritin levels, and nutritional education in influencing the risk of postpartum depression among pregnant women, urging for proactive measures during routine prenatal care.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More